Post-Licensure Safety Study of ISENTRESS™ (Raltegravir) in a United States Managed Care Network (MK-0518-268)

Clinical trial NCT01078246 · COMPLETED

Trial details

NCT number: NCT01078246
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Study type: OBSERVATIONAL

HIV-1 Infections

Start date: 2009-08-31
Primary completion: 2014-12-09
Enrollment: 7124

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.